Protein kinase C in melanoma

Cancer and Metastasis Reviews

Volumn 24, Issue 2, 2005, Pages 287-300

  Oka, Masahiro ^a   Kikkawa, Ushio ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Growth; Metastasis; Phorbol ester; Protein kinase C (PKC); TPA

Indexed keywords

DIACYLGLYCEROL; MELANIN; PHORBOL ESTER; PHOSPHOLIPID; PROTEIN KINASE C; RETINOIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CANCER INVASION; CARCINOGENESIS; CATALYSIS; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; DNA SYNTHESIS; ENZYME ACTIVATION; GENE DELETION; GENE MUTATION; HUMAN; KNOCKOUT MOUSE; LIPID HYDROLYSIS; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA CELL; METASTASIS; MITOSIS INHIBITION; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; HUMANS; MELANOCYTES; MELANOMA; NEOPLASM METASTASIS; PROTEIN KINASE C; SKIN NEOPLASMS;

EID: 21544442035     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-005-1578-8     Document Type: Article

References (88)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000
2. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984
3. Nishizuka Y: Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63: 1892-1903, 1989
4. Polsky D, Cordon-Cardo C: Oncogenes in melanoma. Oncogene 22: 3087-3091, 2003
5. Inoue M, Kishimoto A, Takai Y, Nishizuka Y: Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 252: 7610-7616, 1977
6. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 254: 3692-3695, 1979
7. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273-2276, 1980
8. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982
9. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995
10. Ohno S, Nishizuka Y: Protein kinase C isotypes and their specific functions: Prologue. J Biochem 132: 509-511, 2002
11. Eisinger M, Marko O: Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79: 2018-2022, 1982
12. Halaban R, Ghosh S, Duray P, Kirkwood JM, Lerner AB: Human melanocytes cultured from nevi and melanomas. J Invest Dermatol 187: 95-101, 1986
13. Becker D, Beebe SJ, Herlyn M: Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. Oncogene 5: 1133-1139, 1990
14. Brooks G, Birch M, Hart IR: Effects of biologically active tumour-promoting and non-promoting phorbol esters on in vitro growth of melanocytic cells. Pigment Cell Res 3: 98-100, 1990
15. Niles RM: Vitamin A (retinoids) regulation of mouse melanoma growth and differentiation. J Nutr 133: 282S-286S, 2003
16. Lahn MM, Sundell KL: The role of protein kinase C-alpha (PKC-alpha) in melanoma. Melanoma Res 14: 85-89, 2004
17. Yamanishi DT, Meyskens FL Jr: Alterations in gene expression and signal transductions in human melanocytes and melanoma cells. Crit Rev Oncog 5: 429-450, 1994
18. Watters DJ, Parsons PG: Critical targets of protein kinase C in differentiation of tumour cells. Biochem Pharmacol 58: 383-388, 1999
19. La Porta CA: nPKCδ a new therapeutic marker for melanoma metastasis? (Review) Int J Mol Med 5: 467-471, 2000
20. Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL Jr: The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis 12: 105-109, 1991
21. Arita Y, O'Driscoll KR, Weinstein IB: Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res 52: 4514-4521, 1992
22. Powell MB, Rosenberg RK, Graham MJ, Birch ML, Yamanishi DT, Buckmeier JA, Meyskens FL Jr: Protein kinase C beta expression in melanoma cells and melanocytes: Differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate. J Cancer Res Clin Oncol 119: 199-206, 1993
23. Park HY, Russakovsky V, Ohno S, Gilchrest BA: The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 268: 11742-11749, 1993
24. Oka M, Ogita K, Ando H, Kikkawa U, Ichihashi M: Differential down-regulation of protein kinase C subspecies in normal human melanocytes: Possible involvement of the zeta subspecies in growth regulation. J Invest Dermatol 105: 567-571, 1995
25. Oka M, Ogita K, Ando H, Horikawa T, Hayashibe K, Saito N, Kikkawa U, Ichihashi M: Deletion of specific protein kinase C subspecies in human melanoma cells. J Cell Physiol 167: 406-412, 1996
26. Shoji T, Park HY, Jalbert N, Bhawan J, Byers HR: In situ and in vitro expression of protein kinase C alpha in human melanocytes. Pigment Cell Res 11: 18-23, 1998
27. Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP: Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: A result of transformation or differentiation? Melanoma Res 11: 355-369, 2001
28. Selzer E, Okamoto I, Lucas T, Kodym R, Pehamberger H, Jansen B: Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res 12: 201-209, 2002
29. Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE: Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells. Int J Oncol 20: 865-871, 2002
30. Brooks G, Goss MW, East JA, Hart IR: Growth of melanocytic cells is associated with down-regulation of protein kinase C alpha, delta, and epsilon isoforms. Possible role of diacylglycerol. J Biol Chem. 268: 23868-23875, 1993
31. Mapelli E, Banfi P, Sala E, Sensi M, Supino R, Zunino F, Gambetta RA: Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int J Cancer 57: 281-286, 1994
32. Arita Y, Buffolino P, Coppock DL: Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Exp Cell Res 242: 381-390, 1998
33. Watters D, Garrone B, Coomer J, Johnson WE, Brown G, Parsons P: Stimulation of melanogenesis in a human melanoma cell line by bistratene A. Biochem Pharmacol 55: 1691-1699, 1998
34. Dennis JU, Dean NM, Bennett CF, Griffith JW, Lang CM, Welch DR: Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett 128: 65-70, 1998
35. La Porta CA, Porro D, Comolli R: Higher levels of melanin and inhibition of cdk2 activity in primary human melanoma cells WM115 overexpressing nPKCdelta. Melanoma Res 12: 297-307, 2002
36. Oka M, Kageshita T, Ono T, Goto A, Kuroki T, Ichihashi M: Protein kinase C alpha associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-independent manner in human melanoma cells. J Invest Dermatol 121: 69-76, 2003
37. Rosenbaum SE, Niles RM: Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells. Arch Biochem Biophys 294: 123-129, 1992
38. Gruber JR, Ohno S, Niles RM: Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 267: 13356-13360, 1992
39. Oka M, Ogita K, Saito N, Mishima Y: Selective increase of the alpha subspecies of protein kinase C and inhibition of melanogenesis induced by retinoic acid in melanoma cells. J Invest Dermatol 100: 204S-208S, 1993
40. Liu B, Khan WA, Hannun YA, Timar J, Taylor JD, Lundy S, Butovich I, Honn KV: 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids. Proc Natl Acad Sci USA 92: 9323-9327, 1995
41. Sullivan RM, Stone M, Marshall JF, Uberall F, Rotenberg SA: Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58: 729-737, 2000
42. Raso E, Tovari J, Toth K, Paku S, Trikha M, Honn KV, Timar J: Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells. Thromb Haemost 85: 1037-1042, 2001
43. Szalay J, Bruno P, Bhati R, Adjodha J, Schueler D, Summerville V, Vazeos R: Associations of PKC isoforms with the cytoskeleton of B16F10 melanoma cells. J Histochem Cytochem 49: 49-66, 2001
44. Zhao X, Murata T, Ohno S, Day N, Song J, Nomura N, Nakahara T, Yokoyama KK: Protein kinase Calpha plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 cells. J Biol Chem 276: 39903-39910, 2001
45. La Porta CA, Comolli R: Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential. Clin Exp Metastasis 15: 568-579, 1997
46. La Porta CA, Di Dio A, Porro D, Comolli R: Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo. Melanoma Res 10: 93-102, 2000
47. Linnenhach AJ, Huebner K, Reddy EP, Herlyn M, Parmiter AH, Nowell PC, Koprowski H: Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines. Proc Natl Acad Sci USA 85: 74-78, 1988
48. Gordon PR, Gilchrest BA: Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol 93: 700-702, 1989
49. Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA: Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 274: 16470-16478, 1999
50. Park HY, Lee J, Gonzalez S, Middelkamp-Hup MA, Kapasi S, Peterson S, Gilchrest BA: Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol 122: 159-166, 2004
51. Arita Y, Santiago-Schwarz F, Coppock DL: Survival mechanisms induced by 12-O-tetradecanoylphorbol-13-acetate in normal human melanocytes include inhibition of apoptosis and increased Bcl-2 expression. Melanoma Res 10: 412-420, 2000
52. Oka M, Kageyama A, Fukunaga M, Bito T, Nagai T, and Nishigori C: Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis in normal human melanocytes. J Invest Dermatol 123: 930-936, 2004
53. Brooks G, Wilson RE, Dooley TP, Goss MW, Hart IR: Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth. Cancer Res 51: 3281-3288, 1991
54. Coppock DL, Tansey JB, Nathanson L: 12-O-tetradecanoylphorbol-13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: Inhibition of phosphorylation of p34cdc2. Cell Growth Differ 3: 485-494, 1992
55. Krasagakis K, Lindschau C, Fimmel S, Eberle J, Quass P, Haller H, Orfanos CE: Proliferation of human melanoma cells is under tight control of protein kinase C alpha. J Cell Physiol 199: 381-387, 2004
56. Fink-Puches R, Helige C, Kerl H, Smolle J, Tritthart HA: Inhibition of melanoma cell directional migration in vitro via different cellular targets. Exp Dermatol 2: 17-24, 1993
57. Timar J, Toth S, Tovari J, Paku S, Raz A: Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events. Clin Exp Metastasis 17: 809-816, 1999
58. Sanz-Navares E, Fernandez N, Kazanietz MG, Rotenberg SA: Atypical protein kinase Czeta suppresses migration of mouse melanoma cells. Cell Growth Differ 12: 517-524, 2001
59. Honn KV, Timar J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF: A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res 214: 120-130, 1994
60. Lewis JM, Cheresh DA, Schwartz MA: Protein kinase C regulates αvβ5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J Cell Biol 134: 1323-1332, 1996
61. Rice RL, Tang DG, Haddad M, Honn KV, Taylor JD: 12(S)- hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: A protein kinase-dependent process. Int J Cancer 77: 271-278, 1998
62. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM: Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288, 2002
63. Liscovitch M, Czarny M, Fiucci G, Tang X: Phospholipase D: Molecular and cell biology of a novel gene family. Biochem J 345: 401-415, 2000
64. Foster DA, Xu L: Phospholipase D in cell proliferation and cancer. Mol Cancer Res 1: 789-800, 2003
65. Oka M, Hitomi T, Okada T, Nakamura S, Nagai H, Ohba M, Kuroki T, Kikkawa U, Ichihashi M: Dual regulation of phospholipase D1 by protein kinase C αgn vivo. Biochem Biophys Res Commun 294: 1109-1113, 2002
66. Oka M, Okada T, Nakamura S, Ohba M, Kuroki T, Kikkawa U, Nagai H, Ichihashi M, Nishigori C: PKCδ inhibits PKCα-mediated activation of phospholipase D1 in a manner independent of its protein kinase activity. FEBS Lett 554: 179-183, 2003
67. Kikkawa U, Matsuzaki H, Yamamoto T: Protein kinase C δ. (PKCδ): Activation mechanisms and functions. J Biochem 132: 831-839, 2002
68. Gopalakrishna R, Barsky SH: Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 85: 612-616, 1988
69. Dumont JA, Bitonti AJ: Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem Biophys Res Commun 204: 264-272, 1994
70. Dumont JA, Jones WD Jr, Bitonti AJ: Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res 52: 1195-1200, 1992
71. Liu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA, Honn KV: Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer 52: 147-152, 1992
72. Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M: Effect of PKC412, an inhibitor of protein kinase C, on spontaneous metastatic model mice. Anticancer Res 23: 1395-1399, 2003
73. Kofler K, Erdel M, Utermann G, Baier G: Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biol 3:Research0014.1-0014.10, 2002
74. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, Joubert D: Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77: 1125-1129, 1993
75. Prevostel C, Alvaro V, de Boisvilliers F, Martin A, Jaffiol C, Joubert D: The natural protein kinase C alpha mutant is present in human thyroid neoplasms. Oncogene 17: 669-674, 1995
76. Megidish T, Mazurek N: A mutant protein kinase C that can transform fibroblasts. Nature 342: 807-811, 1989
77. Borner C, Filipuzzi I, Weinstein IB, Imber R: Failure of wild-type or a mutant form of protein kinase C-alpha to transform fibroblasts. Nature 353: 78-80, 1991
78. Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, Kanoh Y, Farese RV: Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol 16: 847-858, 2002
79. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A: Immunodeficiency in protein kinase cbeta-deficient mice. Science 273: 788-791, 1996
80. Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A: Protein kinase C-δ controls self-antigen-induced B-cell tolerance. Nature 416: 860-865, 2002
81. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI: Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C-δ. Nature 416: 865-869, 2002
82. Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK: Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer 93: 635-463, 2001
83. Reddig PJ, Dreckschmidt NE, Ahrens H, Simsiman R, Tseng CP, Zou J, Oberley TD, Verma AK: Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O- tetradecanoylphorbol-13-acetate. Cancer Res 59: 5710-5718, 1999
84. Wheeler DL, Reddig PJ, Dreckschmidt NE, Leitges M, Verma AK: Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression. Oncogene 21: 3620-3630, 2002
85. Wheeler DL, Ness KJ, Oberley TD, Verma AK: Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. Cancer Res 63: 3037-3042, 2003
86. Wheeler DL, Ness KJ, Oberley TD, Verma AK: Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Res 63: 6547-6555, 2003
87. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002
88. Melnikova VO, Bolshakov SV, Walker C, Ananthaswamy HN: Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene 23: 2347-2356, 2004